Updated research and studies about the impact of Vibroacoustic Therapy on physical and psychological systems
- avigail berg-panitz
- 15 hours ago
- 2 min read

Updated Research Library - www.vibro-therapy.com/research
TheSoundWell research library serves as a comprehensive repository for a diverse array of studies specifically focused on the therapeutic potential of the 30 Hz to 120 Hz frequency range. As the exclusive representative of the original Vibroacoustic Therapy (VAT) invented by Olav Skille, TheSoundWell maintains the clinical integrity of this pioneered modality.
Skille's foundational approach involved separating music from therapeutic streaming, focusing instead on pure, sinusoidal low-frequency sound waves that bypass cognitive resistance to reach the body's nervous system and tissues directly. While he approved of ambient background music streamed from separate systems to enhance the environment, the core therapy relies on precise frequencies. Having been personally mentored by Skille, we have integrated his original harmonic frequencies and ergonomic design principles into our hardware, including mats, recliners, and bedding kits.
The lower section of this library features deep research overviews and insights generated by advanced AI platforms such as Gemini, ChatGPT, and Perplexity, alongside immersive NotebookLM podcasts and educational videos. These resources detail how VAT measurably improves sleep quality, reduces chronic pain (such as fibromyalgia), and lowers stress by engaging the autonomic nervous system and the vagus nerve.
We actively invite academic centers and researchers to collaborate with us in exploring the clinical applications listed below, ranging from neurological conditions like Parkinson's to behavioral challenges in autism. This document is updated periodically to reflect the latest evidence-based findings.
Furthermore, we are currently developing a new version of our eBook, which will provide an expanded look into these specialized fields and the "less is more" philosophy of optimal therapeutic usage.



Comments